Update on the optimal use of bortezomib in the treatment of multiple myeloma
Meera Mohan, Aasiya Matin, Faith E Davies Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA Abstract: The proteasome inhibitor (PI) “bortezomib” has now been in routine clinical practice for over a decade. It is now considered an importa...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2017-03-01
|
| Serie: | Cancer Management and Research |
| Soggetti: | |
| Accesso online: | https://www.dovepress.com/update-on-the-optimal-use-of-bortezomib-in-the-treatment-of-multiple-m-peer-reviewed-article-CMAR |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|